(Q39827765)

15 September 2017

1 reference

title

Haemophilus influenzae type b polysaccharide vaccines (English)

1 reference

15 September 2017

1 reference

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

Granoff DM

1

1 reference

15 September 2017

Cates KL

series ordinal

2

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 September 1985

1 reference

The Journal of Pediatrics

15 September 2017

published in

1 reference

15 September 2017

volume

107

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

330-336

1 reference

Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study.

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Active thymus derived suppressor lymphocytes in human cord blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Thymus-independent antigens: complexity of B-lymphocyte activation revealed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Mouse IgG3 antibodies are highly protective against infection with Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Characterization of human antibody to polyribophosphate, the capsular antigen of hemophilus influenzae, type B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

IgG subclasses: Development of the serum concentrations in “normal” infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Class-specific antibody response to Haemophilus influenzae type b capsular polysaccharide vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Polysaccharide Meningococcal Vaccines—Current Status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Immunoglobulin allotypes and immune response to meningococcal group B polysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of Haemophilus meningitis in children with the Km(1) immunoglobulin allotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Siblings of patients with Haemophilus meningitis have impaired anticapsular antibody responses to Haemophilus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Haemophilus influenzae type b disease. Incidence in a day-care center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Haemophilus influenzae infections in Fresno County, California: a prospective study of the effects of age, race, and contact with a case on incidence of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Immunogenicity of Haemophilus influenzae type b polysaccharide--diphtheria toxoid conjugate vaccine in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Purification and comparison of outer membrane protein P2 from Haemophilus influenzae type b isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

Biological activities of immunoglobulins of different classes and subclasses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

7 January 2021

Interactive effect of genes associated with immunoglobulin allotypes and HLA specificities on susceptibility to Haemophilus influenzae disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

7 January 2021

Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

7 January 2021

Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

7 January 2021

A minor high-molecular-weight outer membrane protein of Haemophilus influenzae type b is a protective antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980502-3

7 January 2021

10.1016/S0022-3476(85)80502-3

Identifiers

DOI

1 reference

15 September 2017

1 reference